FDA Investigator Brian M Palermo
Brian M Palermo has inspections in 1 countries as of 20 Feb 2024. Brian M Palermo has collaborated with a combined 1993 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
108
Last Inspection Date:
20 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adams,
Addie V Scott Boston,
Ali Akbar,
Amanda B Athey,
Amanda M Osteen,
Amy A Johnson,
Amy Malla,
Ana P Barido,
Andrea Lwilliams Jones,
Andrew J Howard,
Anita R Michael,
Ashley M Whitehurst,
Austin B Appler,
Barbara J Holladay,
Brandon L Mariner,
Brandon M Kurjanowicz,
Bruce E Kummer,
Carl E Lovrich,
Carrie L Doupnik,
Charles D Boison,
Charles M Kerns, BLT DO,
Cherlita A Honeycutt,
Christopher R Richardson,
Collins,
Courtney N Long,
Cynthia A Harris, MD, RN,
Daniel J Mechenbier,
Dauksism,
David P Rice,
Deborah G Haney Cozzone,
Dennis L Doupnik,
Dennis R Hock,
Dessa A Antoine,
Edward P Potter,
Elvis D Morton,
Erica L Nicoll,
Erin M Holliman,
Esaw,
Estefania Fernandez,
Gail L Katz,
Gale L Glinecki,
Gerald Mierle,
Gerald W Kopp,
Gregory E Beichner,
Hamilton,
Heath A Gerber,
Heath R Harley,
Jacqueline Johnson,
James M Odonnell,
James T Mccoy,
James W Leonette,
Jamie D Swann,
Jefferson,
Jennifer Branham,
John Dan,
Johnson,
Joseph R Hatcher,
Justin A Hefferman,
Kailee R Mason,
Karen A Spencer,
Katelyn Astaub Zamperini,
Kenneth L Smalls,
Kirk A Dymbrowski,
Kyle S Hobson,
La Tasha M Gunter,
Laurissa S Flowers,
Lawrence J Stringer,
LCDR Margaret E Digennaro,
LCDR William H Bender,
Linda S Mattingly,
LT John M Mastalski,
LT Mark A Chen, MPH,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Margaret Torres Vazquez,
Marjorie L Davis,
Matthew R Noonan,
Maureen A Wentzel,
Michael S Call,
Michele M Falchek,
Nancy L Meade,
Nash,
Patricia A Morrow,
Paula J Bretz,
Rachel C Harrington,
Raymond W Niles,
Richard J Bashay,
Robert W Calais,
Samuel M Aboagye,
Sarah Forney,
Shavon L Square,
Shusheen A Alexander,
Sierra M Shockley,
Slatten,
State Agency,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Susan J Essenmacher,
Tamara N Champion,
Tamika E Allen, RN,
Tammy M Phillips,
Tania E Vizcaino,
Theresa M Smedley,
Thomas E Friel,
Thomas R Withers,
Thompsonv,
Travis R Hunt,
Valeria A Moore,
Wayne L Jefferson,
Whitney S Reynolds,
William A Warnick,
William D Bassett, Jr,
William D Murray
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more